Beta Bionics (NASDAQ:BBNX) reported quarterly earnings results on February 17, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.30, beating the consensus estimate of $-0.39 by $0.09 per share. Revenue came in at $32.1M, beating the estimate of $31.5M.
Beta Bionics's stock moved following the earnings release. The stock currently trades at $11.81 with a market capitalization of $1.3B.
